Informationen zu Lehrveranstaltungen in →Opal / Information about lectures can be found in →Opal

Skip to content.

TUD

search  |  internal  |  deutsch
Personal tools
TU Dresden » Faculty of Mechanical Science and Engineering » Institute for Materials Science » Chair of Materials Science and Nanotechnology
» funding   » SmartCatheters - Solution for in vivo real time blood testing


SmartCatheters - Solution for in vivo real time blood testing

()




title:SmartCatheters - Solution for in vivo real time blood testing
agency:Else Kröner-Fresenius Center
program:Else Kröner-Fresenius Center
time frame:2020-2022
publications:project related (p)reprints listing (with link to the pdf files)

description:

Even if point-of-care devices and rapid processing central laboratory services are available, these measurements remain discontinuous and do not enable individualized treatment approaches in dynamic and rapidly changing critical situations. Furthermore, a considerable amount of blood is needed when laboratory tests are applied frequently, sometimes even requiring transfusion of blood or blood products. Real time measurement of key parameters (e.g. lactate, electrolytes, glucose, oxygenation, acid-base status) would improve patient care and individualized treatment. Indwelling catheters are routinely placed in critically ill patients to allow hemodynamic monitoring and/or administration of potent drugs. We aim at developing smart electrochemical micro-sensors, placed on such indwelling catheters to provide continuous monitoring of essential parameters, without increased consumption of blood or use of additional sensor interfaces. Such sensors will integrate all necessary components on a smart catheter for reagentless and real time analysis, including selective membranes that protect the surface from deterioration. Therefore, online measurements of key laboratory values such as blood gases would certainly improve quality of care towards more individualized therapeutic approaches. Moreover, the measurement of glucose and lactate levels would allow direct monitoring and response in dynamic situations in critically ill patients. Glucose plays a central role when monitoring liver function in patients with multi-organ failure or acute diabetic states e.g. after total pancreatectomy. Lactate is one of the best established markers representing adequate tissue (micro-) perfusion, frequently used in different states of shock, especially for guiding fluid resuscitation and differentiated catecholaminergic support. This approach will enable patient-centered, individualized therapy guidance and therefore improve quality of care, patient safety and outcome in critically ill patients.



last modified: 2021.05.05 Wed
author: webadmin